SENORES PHARMACEUTICALS L - Asset Resilience Ratio

Latest as of March 2026: 17.88%

SENORES PHARMACEUTICALS L (SENORES) has an Asset Resilience Ratio of 17.88% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SENORES working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs2.87 Billion

≈ $31.01 Million USD Cash + Short-term Investments

Total Assets

Rs16.04 Billion

≈ $173.45 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2022–2026)

This chart shows how SENORES PHARMACEUTICALS L's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see SENORES PHARMACEUTICALS L balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down SENORES PHARMACEUTICALS L's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read how much debt does SENORES PHARMACEUTICALS L carry for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs2.87 Billion	17.88%
Total Liquid Assets	Rs2.87 Billion	17.88%

Asset Resilience Insights

Good Liquidity Position: SENORES PHARMACEUTICALS L maintains a healthy 17.88% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

SENORES PHARMACEUTICALS L Industry Peers by Asset Resilience Ratio

Compare SENORES PHARMACEUTICALS L's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Pfizer Inc NYSE:PFE	Drug Manufacturers - General	5.33%
AbbVie Inc NYSE:ABBV	Drug Manufacturers - General	0.02%
Merck & Company Inc NYSE:MRK	Drug Manufacturers - General	0.22%
AstraZeneca PLC MX:AZNN	Drug Manufacturers - General	0.03%
Novartis AG ADR NYSE:NVS	Drug Manufacturers - General	0.06%
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd SHE:300357	Drug Manufacturers - General	9.91%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	6.46%

Annual Asset Resilience Ratio for SENORES PHARMACEUTICALS L (2022–2026)

The table below shows the annual Asset Resilience Ratio data for SENORES PHARMACEUTICALS L.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	17.88%	Rs2.87 Billion ≈ $31.01 Million	Rs16.04 Billion ≈ $173.45 Million	+17.04pp
2024-03-31	0.84%	Rs52.08 Million ≈ $563.23K	Rs6.22 Billion ≈ $67.25 Million	-1.18pp
2022-03-31	2.02%	Rs11.95 Million ≈ $129.23K	Rs591.52 Million ≈ $6.40 Million	--

pp = percentage points

About SENORES PHARMACEUTICALS L

NSE:SENORES India Drug Manufacturers - General

Market Cap

$698.57 Million

Rs64.59 Billion INR

Market Cap Rank

#10670 Global

#533 in India

Share Price

Rs1402.60

Change (1 day)

+0.00%

52-Week Range

Rs673.60 - Rs1550.90

All Time High

Rs1550.90